Livongo Health (NASDAQ:LVGO) Shares Gap Up to $17.32

Livongo Health (NASDAQ:LVGO)’s share price gapped up prior to trading on Monday . The stock had previously closed at $15.40, but opened at $17.32. Livongo Health shares last traded at $20.50, with a volume of 2,915,435 shares trading hands.

Several brokerages recently weighed in on LVGO. Piper Jaffray Companies began coverage on Livongo Health in a research note on Monday, August 19th. They issued an “overweight” rating and a $40.00 price target for the company. JPMorgan Chase & Co. began coverage on Livongo Health in a research note on Monday, August 19th. They issued an “overweight” rating and a $43.00 price target for the company. Needham & Company LLC began coverage on Livongo Health in a research note on Monday, August 19th. They issued a “buy” rating and a $42.00 price target for the company. Svb Leerink began coverage on Livongo Health in a research note on Monday, August 19th. They issued an “outperform” rating and a $50.00 price target for the company. Finally, Goldman Sachs Group began coverage on Livongo Health in a research note on Monday, August 19th. They issued a “buy” rating and a $43.00 price target for the company. One investment analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Livongo Health currently has a consensus rating of “Buy” and a consensus price target of $44.20.

The firm’s 50 day moving average price is $25.57.

Livongo Health (NASDAQ:LVGO) last posted its quarterly earnings data on Thursday, September 5th. The company reported ($0.46) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.17) by ($0.29). The business had revenue of $40.90 million during the quarter, compared to the consensus estimate of $39.74 million. The firm’s revenue for the quarter was up 155.6% compared to the same quarter last year. Sell-side analysts predict that Livongo Health will post -1.29 earnings per share for the current year.

In other news, Director Hemant Taneja acquired 2,678,571 shares of the business’s stock in a transaction on Monday, July 29th. The stock was bought at an average cost of $28.00 per share, for a total transaction of $74,999,988.00. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Also, major shareholder Ab (Publ) Kinnevik acquired 3,141,795 shares of the business’s stock in a transaction on Monday, July 29th. The shares were purchased at an average price of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 5,826,366 shares of company stock valued at $162,980,808.

Livongo Health Company Profile (NASDAQ:LVGO)

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

See Also: What does it mean to hold a stock in street name?

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.